JAMA Cardiology Author Interviews
by JAMA NetworkInterviews with authors of articles from JAMA Cardiology. JAMA Cardiology publishes exceptional original research, state-of-the-art reviews, and informative opinions that advance the science and practice of cardiology, enhance cardiovascular health, and inform health care policy. JAMA Cardiology is the definitive journal for clinical investigators, clinicians, and trainees in cardiovascular medicine worldwide. JAMA Cardiology focuses on all aspects of cardiovascular medicine, including epidemiology and prevention, diagnostic testing, interventional and pharmacologic therapeutics, translational research, health care policy and outcomes, and global health.
Copyright: American Medical Association, 2020
Episodes
Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials
16m · PublishedInterview with Ajay J. Kirtane, MD, SM, author of Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials. Hosted by Clyde W. Yancy, MD, MSc.
Related Content:
- Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials
- Is There a Role for Renal Denervation in the Treatment of Hypertension?
Association of Preexisting Heart Failure With Outcomes in Older Patients With Diffuse Large B-Cell Lymphoma
20m · PublishedInterview with Jenica N. Upshaw, MD, MS, author of Association of Preexisting Heart Failure With Outcomes in Older Patients With Diffuse Large B-Cell Lymphoma, and Ana Barac, MD, PhD, author of Assessing Heart Failure vs Lymphoma Treatment Risks and Benefits—It Takes Two to Tango. Hosted by Robert Bonow, MD.
Related Content:
- Association of Preexisting Heart Failure With Outcomes in Older Patients With Diffuse Large B-Cell Lymphoma
- Assessing Heart Failure vs Lymphoma Treatment Risks and Benefits—It Takes Two to Tango
Prevalence and Prognostic Significance of Bradyarrhythmias in Patients Screened for Atrial Fibrillation vs Usual Care
27m · PublishedInterview with Søren Zöga Diederichsen, MD, PhD, author of Prevalence and Prognostic Significance of Bradyarrhythmias in Patients Screened for Atrial Fibrillation vs Usual Care: Post Hoc Analysis of the LOOP Randomized Clinical Trial, and Mark Schoenfeld, MD, author of Incidental Detection of Bradycardia by Implantable Loop Recorders—Unintended Consequences. Hosted by Kristen K. Patton, MD.
Related Content:
- Prevalence and Prognostic Significance of Bradyarrhythmias in Patients Screened for Atrial Fibrillation vs Usual Care
- Incidental Detection of Bradycardia by Implantable Loop Recorders—Unintended Consequences
Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation
17m · PublishedInterview with Michael J. Reardon, MD, and Daniel O’Hair, MD, authors of Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation in Patients at Intermediate or High Risk. Hosted by Robert O. Bonow, MD, MS.
Related Content:
- Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation in Patients at Intermediate or High Risk
Effect of Nudges to Clinicians, Patients, or Both to Increase Statin Prescribing
16m · PublishedInterview with Mitesh S. Patel, MD, MBA, author of Effect of Nudges to Clinicians, Patients, or Both to Increase Statin Prescribing: A Cluster Randomized Clinical Trial, and Faraz S. Ahmad, MD, MS, author of Nudging to Improve Cardiovascular Care—Clinicians, Patients, or Both. Hosted by Sadiya Sana Khan, MD, MS.
Related Content:
- Effect of Nudges to Clinicians, Patients, or Both to Increase Statin Prescribing
- Nudging to Improve Cardiovascular Care—Clinicians, Patients, or Both
Treatment of Hypertension in 2022
27m · PublishedJAMA Interim Executive Editor Gregory Curfman, MD, interviews Robert M. Carey, MD, University of Virginia, about his review article on treatment of hypertension in the November 8, 2022, issue of JAMA. Their discussion addresses the clinical consequences of hypertension, as well as nonpharmacological and pharmacological approaches to management, including patients with resistant hypertension.
Related Content:
- Treatment of Hypertension
More programs like this one are available via the JAMA Clinical Reviews podcast.
Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control
17m · PublishedInterview with Nicholas M. Pajewski, PhD, author of Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control: A Secondary Analysis of a Randomized Clinical Trial, and Daniel W. Jones, MD, author of Blood Pressure Control After SPRINT—Back to Reality. Hosted by Gregg C. Fonarow, MD.
Related Content:
- Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control
- Blood Pressure Control After SPRINT—Back to Reality
Burden of Rare Genetic Variants in Spontaneous Coronary Artery Dissection With High-risk Features
20m · PublishedInterview with Santhi K. Ganesh, MD, author of Burden of Rare Genetic Variants in Spontaneous Coronary Artery Dissection With High-risk Features, and Sharonne N. Hayes, MD, author of Genetic Testing in High-risk Spontaneous Coronary Artery Dissection—Searching for Clinical Utility Among Background Genetic Noise. Hosted by Sadiya Sana Khan, MD, MS.
Related Content:
- Burden of Rare Genetic Variants in Spontaneous Coronary Artery Dissection With High-risk Features
- Genetic Testing in High-risk Spontaneous Coronary Artery Dissection—Searching for Clinical Utility Among Background Genetic Noise
Alerting Clinicians to 1-Year Mortality Risk in Patients Hospitalized With Heart Failure
17m · PublishedInterview with Tariq Ahmad, MD, MPH, author of Alerting Clinicians to 1-Year Mortality Risk in Patients Hospitalized With Heart Failure: The REVEAL-HF Randomized Clinical Trial, and Rishi K. Wadhera, MD, MPP, MPhil, author of Improving Quality Improvement—From Aspiration Toward Empiricism. Hosted by Gregg C. Fonarow, MD.
Related Content:
- Alerting Clinicians to 1-Year Mortality Risk in Patients Hospitalized With Heart Failure
- Improving Quality Improvement—From Aspiration Toward Empiricism
Association of LV Remodeling Assessment by CMR With Outcomes in Patients With Chronic Aortic Regurgitation
19m · PublishedInterview with João L. Cavalcante, MD, author of Association of Left Ventricular Remodeling Assessment by Cardiac Magnetic Resonance With Outcomes in Patients With Chronic Aortic Regurgitation, and Vidhu Anand, author of Earlier Intervention in Asymptomatic Chronic Aortic Regurgitation—Novel Indicators of Myocardial Overload.Hosted by Robert Bonow, MD.
JAMA Cardiology Author Interviews has 103 episodes in total of non- explicit content. Total playtime is 31:51:48. The language of the podcast is English. This podcast has been added on November 27th 2022. It might contain more episodes than the ones shown here. It was last updated on April 23rd, 2024 23:18.